baber/WOPTO huggingface dataset:
Patent IL-64735-A0 (IL)
Title: Induction heating method and apparatus for use in causing necrosis of neoplasm
IPC: A61N1/40
Filed: 1982-01-08
Abstract: The composition comprises magnetic particles which can undergo hysteresis heating and a pharmacologically acceptable carrier fluid. The particles have thereon an adherent protective coating of pharmacologically acceptable material and/or the carrier fluid is curable in living tissue (e.g. a polymerisable silicone). 
<??>The apparatus comprises a first induction heating coil with an a.c. power supply (30,32), and at least one further coil (12) provided adjacent and in axial alignment with the first coil. The further coil is electrically isolated from the power supply and connected to form a resonant circuit (26) arranged to resonate when alternating current is passed through the first coil so as to provide additional induction heating.
Patent IL-72681-A0 (IL)
Title: 4-alkylimidazole derivatives,their preparation and their use as nitrification inhibitors
IPC: C07D233/60
Filed: 1984-08-14
Abstract: 4-Alkylimidazole derivatives of the formula I    <IMAGE>  I  where R1 is C1-C4-alkyl, R2 is chlorine or bromine and R3 is an -OR4 or -NR5R6 group in which R4 is C1-C4-alkyl, R5 is hydrogen or C1-C4-alkyl and R6 is C1-C4-alkyl or is phenyl which is unsubstituted or substituted by 1 or 2 halogen atoms, and its salts, their preparation and their use as nitrification inhibitors.
Patent IL-74646-A0 (IL)
Title: Analytical process and agents for the detection of esterolytic and/or proteolytic enzymes
IPC: C12Q1/34
Filed: 1985-03-19
Abstract: Agent for the detection of esterolytic and/or proteolytic enzymes, containing (a) an amino acid ester or peptide ester of a phenol, as the chromogenic enzyme substrate, and (b) an alcohol as the substance which accelerates the enzymatic cleavage of the amino acid ester bond or peptide ester bond of component (a), characterized in that it contains a salt as the accelerating substance.
Patent IL-91410-A0 (IL)
Title: Sulphonamidocycloalkane compounds,processes for the preparation thereof and pharmaceutical compositions containing them
IPC: C07D257/06
Filed: 1989-08-24
Abstract: The present invention provides sulphonamides of the general formula:    <IMAGE>  (I)  wherein R1 and R2, which can be the same or different, are hydrogen or halogen atoms or C1-C6-alkyl, trifluoro-methyl, cyano, carboxyl, alkoxycarbonyl, aminocarbonyl, N-alkylaminocarbonyl or N,N-dialkylaminocarbonyl radicals or, when R1 and R2 are alkyl radicals ortho to one another, R1 and R2 together with the carbon atoms to which they are attached, form a saturated or unsaturated C5-C7-alkylene ring, R3 is a hydrogen atom, an alkyl radical containing up to 6 carbon atoms, an acyl radical, a phenylalkyl or phenylalkenyl radical, the phenyl moiety of which can be substituted by halogen, alkyl or trifluoromethyl, C is a -(CH2)m-radical, in which m is 0, 1, 2 or 3, or a branched C2-C5-alkylene radical, whereby a methylene radical -CH2-of the group C can be replaced by an oxygen or sulphur atom or by a hydroxymethylene radical -CHOH-or carbonyl group -CO-, B is a 1,2-, 1,3-, 1,4-cyclohexylidene or 1,2- or 1,3-cyclopentylidene radical.
Patent IL-91727-A0 (IL)
Title: Method of forming metal matrix composite bodies by utilizing a crushed polycrystalline oxidation reaction product as filler and products produced thereby
IPC: B22D19/14
Filed: 1989-09-21
Abstract: The present invention relates to a novel method for forming metal matrix composite bodies and novel metal matrix composite bodies produced thereby. Particularly, a polycrystalline oxidation reaction product of a parent metal and an oxidant is first formed. The polycrystalline oxidation reaction product is thereafter comminuted into an appropriately sized filler material (2) which can be placed into a suitable container (4) or formed into a preform. The filler material or preform of comminuted polycrystalline oxidation reaction product (2) is thereafter placed into contact with a matrix metal alloy (1) in the presence of an infiltration enhancer, and/or an infiltration enhancer precursor and/or an infiltrating atmosphere, at least at some point during the process, whereupon the matrix metal alloy (1) spontaneously infiltrates the filler material or preform. As a result of utilizing comminuted or crushed polycrystalline oxidation reaction product, enhanced infiltration (e.g., enhanced rate or amount) is achieved. Moreover, novel metal matrix composite bodies are produced.
Patent IL-96838-A0 (IL)
Title: Process for the preparation of phosphinate esters
IPC: C07F9/32
Filed: 1990-12-31
Abstract: An increase in the diastereoselectivity resulting from the reaction of a phosphinic acid ester of the formula <CHEM>  with the halo ester of the formula <CHEM> is achieved by carrying out the reaction in the presence of 4-methylmorpholine, diazabicyclooctane, quinuclidine, 1-methylpyrolidine, or cinchonidine. After removal of the R3 protecting group and fractional crystallization, the resulting desired diastereomeric pair can be resolved, and the desired isomer can be coupled to 4-substituted L-proline to give compounds possessing angiotensin converting enzyme inhibition activity. In particular, the process is useful in producing the antihypertensive agent fosinopril sodium in increased yields.
Patent IL-97040-A0 (IL)
Title: Novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
IPC: A61P31/04
Filed: 1991-01-24
Abstract: Deoxymulundocandin, a compound of the formula I <CHEM> has an antiyeast, an antifungal and an immunomodulatory action.
Patent SE-9903482-A0 (SE)
Inventor: FELIX NILSSON
IPC: H01Q9/04
Filed: 1999-09-27
Abstract: ABSTRACT An antenna module comprises a frame (20) with connecting means for providing electrical contact with a piece of electric equipment of a printed circuit board, and an antenna body (10) having at least one antenna element (12) provided on said body, said antenna body being mounted to said frame. The antenna body comprises an electrically conducting layer (14a, 14b) provided on said body, electrically connected to the antenna element and adapted for co-operation with a connector (22a, 22b) of the connecting means of the frame, thereby electrically connecting the antenna element to the piece of electric equipment.
Patent AU-PN201295-A0 (AU)
Title: Simplified conditions and configurations for phase-contrast imaging with hard x-rays
IPC: G21K1/06
Filed: 1995-03-28
Abstract: A method of obtaining an image of a boundary of an object, the boundary representing a refractive index variation, the method including irradiating the boundary with penetrating radiation having high lateral spatial coherence and a propagation component transverse to the refraction index variation, and receiving at least a portion of the radiation on an image plane so as to form the image, the radiation having been refracted by the boundary such that the boundary is represented on the image by a corresponding intensity variation. Additionally, the method may also include processing the image to resolve weaker variations.
Patent FI-20031331-A0 (FI)
Inventor: HELENIUS PEKKA
IPC: H05H1/34
Filed: 2003-09-17
Abstract: The invention relates to a cooled plasma torch comprising an electrode, a plasma chamber surrounding the electrode, and a coolant space surrounding the plasma chamber with at least one common wall with the plasma chamber. The plasma torch further comprises means for feeding a coolant medium into the coolant space. The coolant medium pressure is reduced in a fashion that causes a phase change in the coolant medium as it is passed from the coolant feed means to the coolant space, whereby the plasma torch is cooled.
Patent FI-20065399-A0 (FI)
Inventor: JORKAMA MARKO
IPC: F16C/
Filed: 2006-06-12
Abstract: An arrangement of attenuating the vibration in a roll assembly of a fiber web machine, in which assembly the roll (10) being rotatably suspended at its end on bearings in bearing housings (13a, 13b), and the bearing housings being supported on the frame or the foundation of the machine via viscoelastic intermediate piece or pieces (21a, 21b). The loss factor of the intermediate piece is greater than 0.1 at the normal operating conditions of the roll at a frequency range, which is ±10% calculated from the lowest bending eigenfrequency of the roll, and in the each end of the roll the spring constant of the total influence of the intermediate piece or pieces is in the range of 0.04 GN/m-1 GN/m.
Patent IL-100449-A0 (IL)
Title: N-acyl-2,3-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/55
Filed: 1991-12-20
Abstract: The invention relates to novel N-acyl-2,3-benzodiezapine derivatives of the general formula (I), their stereoisomers and acid-addition salts, pharmaceutical compositions containing them and a process for their preparation. In the general formula (I)   R   stands for a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group, or by one or more halogen(s); or R is a benzoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; or R is absent when a double bond exists between the N(3) and C(4) atoms; R<1>   means hydrogen; or R<1> is absent when a double bond exists between the N(3) and C(4) atoms; R<2>   means a C1-3 alkyl group; or R<1> and R<2>   together stand for a methylene group and no double bond is present between the N(3) and C(4) atoms; R<3>   means hydrogen or a C1-4 aliphatic acyl group; R<4>   represents hydrogen; a C1-6 aliphatic acyl group optionally substituted by a methoxy, cyano, carboxyl, amino, C1-4 alkylamino, di(C1-4 alkyl)amino, pyrrolidino, phthalimido or phenyl group or by one or more halogen(s); as well as a benzoyl, palmitoyl, cyclopropanecarbonyl, C1-5 alkylcarbamoyl or phenylcarbamoyl group; and the dotted lines represent valence bonds optionally being present, with the proviso that no double bond exists between the N(3) and C(4) atoms when both R<3> and R<4> stand for hydrogen. The compounds of the general formula (I) possess valuable central nervous system effects, particularly muscle-relaxant, anticonvulsive and neuroprotective action. Thus, they may be useful for the treatment of various diseases of central nervous system origin.
Patent IL-108102-A0 (IL)
Title: Water dispersible granular herbicidal compositions
IPC: A01N41/06
Filed: 1993-12-20
Abstract: The present invention relates to water dispersible granular compositions comprising a dinitroaniline herbicide, alone, or in combination with an imidazolinone herbicide, and a dispersion enhancing agent, and to a process for the preparation of said compositions. Such compositions are storage stable and contain desirable dispersion properties.
Patent IL-109479-A0 (IL)
Title: A process for preparing 2-(1-cyclohexenyl) -ethylamine
IPC: C07C211/25
Filed: 1994-04-28
Abstract: A novel process for the preparation of 2-(1-cyclohexenyl)ethylamine by reduction of 2-phenylethylamine with lithium in the presence of a primary or secondary aliphatic alkylamine is described. 2-(1-Cyclohexenyl)ethylamine can be used as a starting material for the preparation of dextromethorphan, a cough-relieving pharmaceutical.
Patent IL-129028-A0 (IL)
Title: Method for in vitro determination of erythropoietin bioactivity
IPC: C07K14/505
Filed: 1996-09-20
Abstract: The present invention is directed to an in vitro method of determining the in vivo EPO activity of a sample containing EPO. More particularly, the present method comprises treating a sample containing EPO under conditions which remove desialylated EPO, and measuring the in vitro EPO activity of the resulting treated sample. In a preferred embodiment, desialylated EPO is removed from the sample by incubating the sample with cells of the human hepatoma cell line HepG2, and in vitro EPO activity is determined by incubating the treated sample with cells of an EPO-responsive cell line and measuring the proliferation or viability of the EPO-responsive cells. The present invention is useful, for example, in quantitating the biologically active EPO in a variety of sample types.
Patent IL-131011-A0 (IL)
Title: Method and mixing head for producing a reaction mixture from an isocyanate and a higher-viscous polyol formulation
IPC: B29C67/24
Filed: 1998-02-04
Abstract: The present invention is directed to an agitator-free mixing head and a method for agitator-free production of a reaction mixture from an isocyanate and a higher-viscous polyol formulation, wherein both constituents are fed to a mixing zone and mixed with each other therein, whereby a polyol formulation with a viscosity of at least 3000 mPa.s is fed at low pressure into the mixing zone and at least two flows of low-viscosity constituents (isocyanate and optionally low-viscous polyol) are injected into the flow of high-viscous polyol formulation at high pressure.
Patent IL-135309-A0 (IL)
Title: Three-dimensional optical memory
IPC: G11B7/241
Filed: 2000-03-28
Abstract: The present invention is directed to a three-dimensional memory apparatus for storing information in a volume comprising of an active medium. The active medium is capable of changing from a first to a second isomeric form as a response to radiation of a light beam having an energy substantially equal to a first threshold energy. The concentration ratio between a first and a second isomeric form in any given volume portion represents a data unit. The active medium in the memory apparatus comprises of diarylalkene derivatives, triene derivatives, polyene derivatives or a mixture thereof. The invention is further directed to means for reading the data units from the isomeric states of the active medium in different portions of said active medium where the two isomeric forms have a substantially different absorption coefficient for absorbing energy of a second threshold energy. Reading may also be carried out by measuring the scattering pattern of the two isomeric forms.
Patent IL-140536-A0 (IL)
Title: A method for introducing recessive properties into the genetic background of industrial baker's yeast
IPC: C12N1/18
Filed: 2000-12-25
Abstract: This invention relates to a novel method of stably introducing a property of a particular yeast strain, which is based on a recessive allele, into the genetic background of an industrial baker's yeast thus being able to combine the properties of industrial baker's yeast with those traits of other yeast strains, which traits are based on recessive alleles. The invention further relates to yeast strains obtainable according to the method described. In particular, a method is disclosed to introduce a lti property into the genetic background of industrial baker's yeast. The novel strains obtained according to the method may be used for the preparation of a dough and for the manufacture of baked products therefrom on an industrial scale.
Patent IL-141199-A0 (IL)
Title: Method for producing a biological substance, biological substance and the use thereof
IPC: A61Q17/04
Filed: 1999-08-04
Abstract: Preparation of a substance (I) involves producing a stirrable first substance (II) by crushing kernels or nuts with addition of a first liquid in 100:(50-100) weight ratio and treating (II) with oil or liquefied fat in less than 100:300 to 100:500 weight ratio to give a second substance, which is acidified to give a firmer consistency. An independent claim is also included for the substance produced in this way.
Patent IL-150335-A0 (IL)
Title: Method for the preparation of citalopram
IPC: C07C213/00
Filed: 1999-12-28
Abstract: The present invention relates to a method for the preparation of citalopram or any of its enantiomers and acid addition salts thereof comprising reaction of a compound of formula II  with a diene having the formula  wherein X is O, S, SO2, -N=N-, -CO-O-, -O-CO-, or or with a diene having the formula  wherein R is alkyl or optionally substituted aryl or arylalkyl. The invention also relates to intermediates used in the new process for the preparation of citalopram, as well as citalopram prepared according to the new process.
Patent IL-154772-A0 (IL)
Title: Method and apparatus for high data rate transmission in a wireless communication system
IPC: H04B7/26
Filed: 2001-09-12
Abstract: In a wireless communication system a method for high data rate transmission aggregates information signals processed by at least two modems, wherein the modulated information signals are transmitted using two carrier frequencies. The method provides multiple data transmissions concurrently over a broad bandwidth consistent with single transmission air-interface standards. An apparatus, mobile unit, includes a multi-link (ML) protocol processor that aggregates the information signals from the modems into a point-to-point protocol (PPP) format for interface with conventional data-based systems, such as the internet. The ML processor further receives an aggregated bundle and separates the bundle into its constituent parts for modulation by the modems.
Patent IL-177378-A0 (IL)
Title: Form iii crystalline (r-r*r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methylethyl)3-phenyl-4-(phenylamino)carbonyl)-ih-pyrrole-1-heptanoic acid hemi calcium salt ( atorvastatin)
IPC: C07D207/34
Filed: 2006-08-08
Abstract: A novel crystalline form of [(R-(R*,R*)]-2-(4-fluorophenyl)- beta , delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form III is characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation and pharmaceutical composition of the same, which is useful as an agent for treating hyperlipidemia and hypercholesterolemia.
Patent IL-180654-A0 (IL)
Title: Substituted oxindol derivatives and medicaments containing the same
Filed: 2007-01-11
Abstract: 1-sulfonyl-2-oxo-2,3-dihydroindole derivatives (I) and their tautomers, enantiomers and/or diastereomers, prodrugs and salts are new. 1-sulfonyl-2-oxo-2,3-dihydroindole derivatives of formula (I) and their tautomers, enantiomers and/or diastereomers, prodrugs and salts are new. A : 6-10C aryl (optionally substituted); B : (partially) aromatic 6-10C mono- or bi-cyclic residue (optionally substituted); R 1>H, 1-6C alkyl, OH, 1-4C alkoxy, di(1-4C alkyl)amino, CN, carbamoyl, trifluoromethoxy, trifluoromethyl, bromo, fluoro, chloro, iodo, nitro, formamido, 1-4C alkylcarbonylamino or ureido; R 2>H, 1-4C alkyl, 1-4C alkoxy, chloro or fluoro; R 3>W-X-Y-Z; W : 1-4C alkylene, (0-4C alkylene)-O-(0-4C alkylene) or (0-4C alkylene)-NR 15>-(0-4C alkylene); R 15>H or 1-4C alkyl; X : CO, SO 2, C=NH or C=N-CN; Y : e.g. pyrrolidindiyl, piperazindiyl or piperidindiyl (optionally substituted); and Z : e.g. pyrrolidinyl, azepinyl or morpholino. The full definitions are given in the DEFINITIONS (Full Definitions) field. An independent claim is also included for two methods for preparing (I). [Image] ACTIVITY : Uropathic; Antithrombotic; Anticoagulant; Hypotensive; Cardiant; Antianginal; Antiischemic; Nephrotropic; Antiinflammatory; Antidiuretic; Hepatotropic; Antiulcer; Antiemetic; Antidepressant; Tranquilizer; Nootropic; Neuroprotective. MECHANISM OF ACTION : Vasopressin receptor antagonist, e.g. V 1a and V 1b receptor antagonist. N-(1-(2,4-dimethoxybenzenesulfonyl-5-chloro-2-oxo-3-(2-methoxyphenyl)-2,3-dihydro-1H-indol-3-yl) 4-(1-methylpiperidin-4-yl)-piperazine-1-carboxamide dihydrochloride (Ia) had affinity constant for the V 1a receptor below 100 nM, when tested by the method of Br. J. Pharmacol., 125 (1998) 1463.
Patent IL-181592-A0 (IL)
Title: Enteral feeding pump and feeding set therefor
Filed: 2007-02-27
Abstract: An enteral feeding pump and feeding set for use to deliver a supply of liquid to a patient. The feeding set has a conduit for the nutrient liquid and a safety interlock device associated with the conduit. The enteral feeding pump has a pumping device and a control system for controlling operation of the pump. An electromagnetic radiation source operatively connected to the control system of the enteral feeding pump emits an electromagnetic radiation signal in a direction for striking the safety interlock device of the feeding set. The safety interlock device is adapted to affect the direction of the electromagnetic radiation. An electromagnetic radiation detector is operatively connected to the control system for receiving the electromagnetic radiation signal when the direction is affected by the safety interlock device, and provides an indication to the control system that the feeding set conduit is properly positioned in the enteral feeding pump.
Patent IL-183576-A0 (IL)
Title: Coated cemented carbide milling insert for cast iron
Filed: 2007-05-31
Abstract: The present invention relates to a coated cemented carbide milling insert for either wet or dry machining of cast iron such as nodular cast iron (NCI), grey cast iron (GCI), austempered ductile iron (ADI) and compacted graphite iron (CGI) where a high wear resistance and an excellent resistance against thermo cracks are required comprising: 
-a substrate comprising 5-7 wt-% Co, 140-250 ppm Ti+Ta and balance WC with a weight ratio Ti/Ta of 0.8-1.3 and 
-a PVD-layer consisting of Al x Ti 1-x N, with x 0.50-0.70 and with a thickness of 1-10 µm. 
The invention also relates to a method for making cutting tool inserts.
Patent IL-189744-A0 (IL)
Title: Scalable freight loading system, especially for an aircraft
Filed: 2008-02-25
Abstract: The invention relates to a scalable freight loading system, especially for an aircraft, said system comprising drive means (L1-L9, R1-R9), covering sensors, bolts, proximity switches (PL1-PL9, PR1-PR9), and a central control device (CCB). According to the invention, the loading surface is divided into sectors (S1, S2, S3); a local control unit (SCB1, SCB2, SCB3) is associated with each sector; the drive means, covering sensors, and proximity switches of a sector are connected to IO ports of the local control unit; and the local control units are connected to the central control unit by means of a bus system (CAN-Bus).
Patent RO-126165-A0 (RO)
Title: Experimental process for inducing the acute alithiasic cholecystitis on laparoscopic way by using l-alpha-phosphatidyl choline
Inventor: STANCU BOGDAN
IPC: G09B23/00
Filed: 2010-02-23
Abstract: The present invention relates to an experimental model for inducing the acute alithiasic cholecystitis on laparoscopic way by using L-alpha-phosphatidylcholine, which is administered laparoscopically by intracholecyst injection to an experiment animal. The model involves injecting two flasks of 250 mg of L-alpha-phosphatidylcholine, achieving a biliary concentration of 1 mmol/l. After 3 days there is carried out the laparoscopic cholecystectomy and there is achieved the macroscopic intra-surgery and hystopathological marking out of the acute alithiasic cholecystitis induction by Hematoxylin-Eosin stain. On the basis of this experimental model, analogy with human model may be made, this being useful for training laparoscopic surgeons in the treatment of acute alithiasic cholecystitis.